General Information of the Compound
Compound ID |
CP0740002
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
SID56462982
Show/Hide
|
||||||||||||||||||
Synonyms |
56897-53-1
A-alaninamide
AC1L1DZE
AC1Q5P6Q
BPBio1_000446
BSPBio_000404
CARCININE
CHEBI:95262
CHEMBL461024
CTK8C1268
Carcinine
KSC921E6R
Lopac-C-2321
Lopac0_000210
MLS002153803
N-(2-(1H-Imidazol-5-yl)ethyl)-3-aminopropanamide
N-[2-(1H-imidazol-5-yl)ethyl]-beta-alaninamide
N-beta-alanylhistamine
Prestwick0_000422
Prestwick1_000422
Prestwick2_000422
Prestwick3_000422
SCHEMBL19051459
SCHEMBL2819350
SPBio_002343
UNII-WIV0W167TC
WIV0W167TC
beta-Alanylhistamine
beta-alaninylhistamine
n-[2-(1h-imidazol-5-yl)ethyl]-
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C8H14N4O
|
||||||||||||||||||
Molecular Weight |
182.227
|
||||||||||||||||||
Canonical SMILES |
NCCC(=O)NCCc1c[nH]cn1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C8H14N4O/c9-3-1-8(13)11-4-2-7-5-10-6-12-7/h5-6H,1-4,9H2,(H,10,12)(H,11,13)
Show/Hide
|
||||||||||||||||||
InChIKey |
ANRUJJLGVODXIK-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06109, Geminin
Protein ID: PT01173, Histamine H3 receptor
Clinical Information about the Compound